The human insulin receptor is a homodimer consisting of two monomers linked by disulfide bonds. Each monomer comprises an ␣-chain that is entirely extracellular and a ␤-chain that spans the cell membrane. The ␣-chain has a total of 37 cysteine residues, most of which form intrachain disulfide bonds, whereas the ␤-chain contains 10 cysteine residues, four of which are in the extracellular region. There are two classes of disulfide bonds in the insulin receptor, those that can be reduced under mild reducing conditions to give ␣-␤ monomers (class I) and those that require stronger reducing conditions (class II). The number of class I disulfides is small and includes the ␣-␣ dimer bond Cys 524 . In this report we describe the use of cyanogen bromide and protease digestion of the exon 11 plus form of the receptor ectodomain to identify disulfide linkages between the ␤-chain residues Cys 798 and Cys 807 and between the ␣-chain Cys 647 and the ␤-chain Cys 872 . The latter bond is the sole ␣-␤ link in the molecule and implies a side-byside alignment of the two fibronectin III domains of the receptor. Also presented is evidence for additional ␣-␣ dimer bond(s) involving at least one of the cysteine residues of the triplet at positions 682, 683, and 685. Evidence is also presented to show that Cys 884 exists as a buried thiol in the soluble ectodomain.
The insulin receptor (IR) 1 is a homodimer, (␣␤) 2 , held together by disulfide bonds. Each ␣␤ monomer comprises an ␣-chain that is entirely extracellular and a ␤-chain that spans the cell membrane via a single transmembrane link to an intracellular segment that includes the protein-tyrosine kinase domain and the domains involved in binding signal transduction proteins (1) . The ␣␤ monomer of the IR is coded for by 22 exons (2) , is synthesized with a 27-residue signal sequence, and is glycosylated, S-S linked, and proteolytically processed in that order during transport to the cell surface (3, 4) . The extracellular region of the mature receptor (the ectodomain) contains the ␣-chain (1-735) and 194 residues of the ␤-chain (the ␤Ј-chain, residues 736 -929). Two isoforms of the IR, which arise by alternative splicing of the mRNA, are expressed in a tissue-specific fashion; they differ by the presence (plus exon 11) or the absence (minus exon 11) of a 12-residue segment close to the C terminus of the ␣-chain (5) .
The ectodomain of the IR has been shown (6, 7) to contain two homologous domains (L1 and L2) separated by a single cysteine-rich region (residues 159 -310). The L2 domain is joined by a connecting domain (residues 471-593) to the Cterminal portion (from residue 594) that is comprised of two fibronectin (Fn) III repeats, the first of which contains an insert domain that includes both the ␣-␤ cleavage site and the alternately spliced exon 11 (8, 9) . A schematic diagram showing the relative arrangement of the domains is shown in Fig. 7 .
The ␣-chain has a total of 37 cysteine residues, whereas the ␤-chain has 4 extracellular and 6 intracellular cysteine residues. Homologous receptors with similar overall structures are the receptor for insulin-like growth factor-I (10) and the insulin receptor-related receptor (11) for which the ligand is not known. The positions of cysteines in the amino acid sequences of these receptors are highly conserved.
Alkylation of the IR suggests that it has one free thiol group per ␣␤ monomer and that this is on the ␤-chain (12) (13) (14) . Mild reduction of the insulin receptor cleaves a small number of disulfide bonds (the class I bonds) giving rise to disulfide-linked ␣␤ monomers that can still bind ligand; more vigorous reduction cleaves the ␣-␤ bond(s) (the class II bonds) leading to free ␣-and ␤-chains and to denaturation of the two protein chains (15) . Some of the disulfide bonds have been established by direct isolation of disulfide-bonded peptides from a tryptic digest of the IR ectodomain. Thus Cys 435 and Cys 468 in the L2 domain are linked in an intrachain disulfide bond, whereas Cys 524 forms an ␣-␣ interchain link, one of the class I disulfides (16) . However, mutation of Cys 524 to Ala (17) or Ser (18) resulted in an IR that was still dimeric, thereby indicating that more than one disulfide bond is involved in dimer formation. Labeling of monomeric IR showed that there are at least two cysteines per monomer involved in class I disulfide bonds (13, 14) . The results of experiments in which Cys 647 was mutated to serine suggested that the IR has only one ␣-␤ disulfide bond (19) . Current models of the IR thus suggest ␣-chains linked to each other to form the dimer with ␤-chains linked only to ␣-chains within each monomer (13, 14) .
In this report the disulfide bond arrangement in the Cterminal half of the IR ectodomain is established. It is shown that the ␣-␤ disulfide link is between Cys 647 in the first Fn III repeat and Cys 872 in the second Fn III repeat, which is consistent with the mutagenesis data (19) ; also identified is an ␣-␣ dimer linkage, in addition to that involving Cys 524 (16) , involving one or more of the triplet of cysteine residues at positions 682, 683, and 685 in the insert domain. Finally we have recovered peptides in which Cys 884 was found cross-linked to Trp in a tryptathionine linkage. We have subsequently shown that this linkage is generated during the CNBr reaction and requires the Cys residue to be present as cysteine not cystine (20) . This suggested that in the ectodomain, Cys 884 exists as a buried thiol, and this was confirmed by isolation and sequence characterization of a peptide from a digest of NEM-labeled IR ectodomain, showing that Cys 884 was derivatized.
EXPERIMENTAL PROCEDURES

Materials
CNBr was from Fluka; iodoacetic acid was obtained from Merck; trifluoracetic acid was Pierce SpectroGrade; HPLC grade acetonitrile was from either BDH or Mallinckrodt; guanidine hydrochloride was from Research Organics Inc. (Cleveland, OH); NEM was from Calbiochem; 3 H-labeled NEM (specific activity, 60 Ci/mmol) was from NEN Life Science Products; Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) was from Strem Chemicals (Newburyport, MA); n-octyl glucoside was from Sigma. Reagents for polyacrylamide gel electrophoresis (PAGE) were obtained from Bio-Rad. Endoproteinase Lys-C was the enzyme from Achromobacter lyticus supplied by Wako Fine Chemicals (Osaka, Japan); sequencing grade endoproteinase Asp-N was from Boehringer Mannheim; trypsin was sequencing grade modified trypsin from Promega; thermolysin was from Calbiochem; peptide N-glycosidase F was from New England BioLabs.
Human IR ectodomain (exon 11 plus) was cloned, expressed in Chinese hamster ovary cells, and purified as described previously (21) . Cloning and expression of human IR ectodomain (exon 11 minus) 2 in cells of the Chinese hamster ovary glycosylation mutant, Lec 8 (22) , were carried out by similar procedures, except that Fibracell discs (Sterilin, UK) were used in a Celligen bioreactor for the fermentation step 3 and the purification protocol used insulin affinity chromatography for the primary purification (21) .
Protein Cleavages
CNBr cleavage was carried out on 10 nmol of human IR ectodomain (exon 11 plus) using the method of Gross and Witkop (23) , except that trifluoracetic acid was used instead of formic acid. Digestions with trypsin or endoproteinase Lys-C were carried out in 0.1 M Tris-HCl buffer, pH 8.5, at 37°C for 16 -18 h using an enzyme to substrate ratio of approximately 1:20; for some digests detergent (0.01% (v/v) Tween 20) was included in the buffer. Digestions with endoproteinase Asp-N were carried out in 50 mM sodium phosphate buffer, pH 8.0, at 37°C for 16 -18 h with an enzyme to substrate ratio of approximately 1:3. Thermolysin digestion was carried out in 1% (w/v) ammonium bicarbonate, 1 mM CaCl 2 , pH 8.2, for 4 h at 37°C with an enzyme to substrate ratio of approximately 1:1. All protease digestions were stopped by acidification with 10% (v/v) trifluoracetic acid and fractionated by RP-HPLC. Digestion with peptide N-glycosidase F was carried out in 0.1 M TrisHCl buffer, pH 8.5, at 37°C for 16 -18 h.
Chromatography
RP-HPLC was carried out on a Hewlett Packard 1090 Liquid Chromatograph using a flow rate of 0.20 ml/min. Linear gradients were formed between buffer A and buffer B where A was ϳ0.1% (v/v) trifluoracetic acid and B was 0.1% (v/v) trifluoracetic acid in 70% (v/v) acetonitrile; the absorbance at 214 nm of A was adjusted to be the same as that of B by addition of trifluoracetic acid. Except where otherwise indicated all chromatography was carried out at room temperature. Fractions were collected manually. Specific conditions for each fractionation are given in the figure legends. Gel filtration chromatography was carried out using a fast protein liquid chromatography system (Pharmacia Biotech Inc.).
Polyacrylamide Gel Electrophoresis and Autoradiography
SDS-PAGE was carried out as described by Laemmli (24) with 7.5% polyacrylamide gels in a Bio-Rad Mini Protean II electrophoresis cell. After staining with Coomassie Blue G250, gels were soaked in Amplify (Amersham Corp.), dried under vacuum, and subjected to autoradiography with Hyperfilm (Amersham Corp.). 
Alkylation of Thiol Groups with [
Preparation of Labeled ␤Ј-Chain
Analytical Methods
Amino acid sequence determinations were carried out on a Hewlett Packard G1005A sequencer. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry was performed with a Bruker Reflex mass spectrometer (Bruker-Franzen Analytik, Bremen, Germany) operated exclusively in the reflectron mode as described previously (25) .
Peptides were diluted in 30% (v/v) aqueous acetonitrile containing 0.1% (v/v) trifluoracetic acid and 2 l of a matrix comprised of 2,6-dihydroxyacetophenone containing diammonium hydrogen citrate (25) prior to deposition of 0.5-1 l onto a stainless steel target. Reduction was achieved by adding diammonium hydrogen citrate to the diluted peptide solutions to a final concentration of 0.2 M followed by TCEP to a final concentration of 10 mM and incubation of the mixture for 20 min at 65°C. A 2-l aliquot of the reduction mixture was mixed with 2 l of a 10 mg/ml solution of 2,6-dihydroxyacetophenone in 50% (v/v) ethanol/ acetonitrile and applied to the sample target of the mass spectrometer (25) .
RESULTS
Cyanogen Bromide Digestion of IR Ectodomain (Exon 11
Plus)-The distribution of the 11 methionine residues in the primary sequence of the IR ectodomain (1) enabled the use of a strategy having cleavage with CNBr as a first step to generate a series of disulfide-bonded fragments (Table I ; see also Fig. 7 ). The fragments resulting from CNBr cleavage of the expressed ectodomain of the human IR (exon 11 plus) (␣␤Ј) 2 were readily separated by RP-HPLC (Fig. 1 ). Fractions 2, 3, 5, 6, and 7 were characterized by further chromatography (not shown) and Nterminal sequence analysis. The sequences obtained (Table II) show that all the peptides expected for cleavage at the 11 methionine residues were present in one or more of these fractions with the exception of the small peptide, CN5, running from Val 99 to Met 110 . The fractionation was complicated by the fact that the N-terminal sequence of peptide CN12 (which contains no cysteine residues) was found across the elution profile in fractions 2, 3, 5, and 6, whereas the sequences of others were found in fewer fractions. This may be due to nonspecific associations or incomplete cleavage.
Cysteine-containing fragments were found in fractions 2, 3, 5, and 6, whereas fraction 7 contained the 42-residue peptide CN4 (Ile 57 -Met 98 ) that contains no cysteine residues. As shown in Table II , fraction 2 contained four peptides, of which two (CN1 and CN2) each contain a single cysteine residue (Table I; see also Fig. 7 ). This suggested that Cys 8 and Cys 26 formed an intrachain disulfide bond. This same pair of peptides was also found in the adjacent fraction 3 along with CN12 and CN11. CN11 is an 83-residue peptide extending from the N terminus of the ␤-chain to Met 818 . It contains cysteines 798 and 807 (Tables I and II; see also Fig. 7) and was purified by rechromatography (giving fraction 3.3; data not shown) prior to tryptic digestion. Fraction 5 contained four CNBr peptides, of which the pair CN10 (residue 554 to the end of the ␣-chain, including four cysteine residues) and CN-13 (residues 844 -929, including two cysteine residues) could not be resolved by further chromatography, suggesting that they contained the ␣-␤ disulfide bond(s) of the IR ectodomain. The remaining cysteines of the IR ectodomain were found in fraction 6, which contained peptides CN6 and CN7, derived from the cysteine-rich and L2 domains of the receptor, and CN8 and CN9 from the L2 and connecting domains (see Fig. 7 ).
Enzymic Digests of Cyanogen Bromide Peptides- Fig. 2 shows the elution profile for RP-HPLC of a tryptic digest of fraction 2 (see Fig. 1 ). Both peaks 2T-9 and 2T-10 had the same two N-terminal sequences starting from Peptides generated by CNBr digestion of 2.2 mg of human IR ectodomain (exon 11 plus) were chromatographed on a Brownlee Aquapore BU-300 cartridge (30 ϫ 2.1 mm) at 0.2 ml/min using a gradient of 5-100% buffer B in 30 min. The elution profile shown was from chromatography of 185 g of total protein.
TABLE II N-terminal amino acid sequences found in fractions obtained by RP-HPLC of CNBr digest of human IR ectodomain
For each cycle the major residues present were identified by reference to the chromatogram of PTH amino acids obtained from the sequencer and then assigned to a possible sequence by reference to the predicted sequences shown in Fig. 1 . Sequences underlined are the major sequences seen in the mixture. X indicates that no PTH amino acid signal within the peptide was seen for that cycle. (Table  III) . Fig. 4A shows the elution profile of a tryptic digest of fraction 5, which includes the two large CNBr fragments CN10 and CN13 (Table II) . Rechromatography of peak 5T-26 (inset, Fig.  4A ) gave two peaks, 5T-26a and 5T-26b. Fraction 5T-26a showed two N-terminal sequences corresponding to Gln 635 -Lys 649 and Tyr 864 -Arg 875 , suggesting that they were disulfide bonded. This was confirmed by mass spectrometry (Table III) , establishing an ␣-␤ interchain disulfide bond between the ␣-chain Cys 647 and the ␤-chain Cys 872 (see Fig. 7 ). Peak 5T-26b was identical to 5T-26a but with the N-terminal glutamine cyclized so that only the sequence Tyr 864 -Arg 875 was observed; the molecular mass (Table III) Although sequences were found for most of the peptides expected to be generated by tryptic digestion of the four CNBr peptides in fraction 5 (Tables I and II) , no peptides containing cysteines 682, 683, 685, or 884 were recovered, and so additional enzymic digestions were carried out.
Fractionation of an endoproteinase Lys-C digest of fraction 5 ( Fig. 4B ) yielded a sharp peak, 5AP-5, which had a single sequence starting at His 670 . Mass spectrometry gave molecular weights of 8966.4 and 4486.8 after reduction with TCEP (Table  III) , confirming that peptide 5AP-5 was a dimer of His 670 -Lys 687 . Further digestion of peptide 5AP-5 with endoproteinase Asp-N gave the two expected peptides (data not shown), one of which, 5AP-5-AspN1, was the glycopeptide His 670 -Glu 676 , and the other, 5AP-5-AspN2, was the disulfide-linked dimer of Asp 677 -Lys 687 . The latter peptide gave the sequence DSAGEXXSXPK (Table III) , where X refers to a lack of PTH signal during sequencing and corresponds to Cys in the known sequence (1). Its molecular weight before reduction was 2192.8, showing it to be a disulfide-linked dimer (calculated weight, 2193.0; Table III) . No mass spectral data could be obtained after reduction of this fragment. These data demonstrated that the dimer disulfide bond(s), in addition to the known bond involving Cys 524 (16, 17) , were between the two ␣-chains and involved one or more of the triplet of Cys residues at 682, 683,
FIG. 2. RP-HPLC of tryptic digest of CNBr fraction 2.
Separation of peptides generated by digestion of fraction 2 with trypsin in the presence of 0.02% Tween 20 on a Vydac C8 column (150 ϫ 2.1 mm) using a gradient of 5-70% buffer B in 50 min.
TABLE III Mass spectral analysis of disulphide-bonded peptides
Residues identified by amino acid sequencing are underlined. X indicates that no PTH amino acid signal was seen for that cycle. Z represents pyroglutamyl. MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight mass spectrometry; ND, not determined. 637 , where X indicates a blank cycle during sequencing. Mass spectrometry of 5AP-21-NglycAspN-17D showed the presence of a single species with a molecular mass equal to the sum of the predicted masses of the two peptides identified by sequence analysis (Table III) .
A cross-link involving a cysteine and a tryptophan residue, the amino acid tryptathionine, is found in peptide toxins from certain mushrooms (26) . We have recently demonstrated that a tryptathionine derivative is formed by reaction of cysteine or cysteine-containing peptides with acetyltryptophan amide in acid solution in the presence of CNBr and that the reaction requires the free thiol of cysteine (20) . These data indicate that the existence of such a tryptathionine cross-link in CNBr fraction 5 is an artifact and that Cys 884 is a thiol in the ectodomain that has undergone a cross-linking reaction with Trp 632 during the CNBr cleavage reaction. It is not present in the expressed IR ectodomain because the ␣-and ␤Ј-chains can be separated by reduction; the thioether bond between Trp 632 in the ␣-chain and Cys 884 in the ␤-chain is not susceptible to reduction.
Confirmation That Cys
884 Is a Free Thiol in the IR Ectodomain before CNBr Digestion-To investigate the possible presence of a cysteine residue at position 884, IR ectodomain (exon 11 minus) was alkylated with [ 3 H]NEM in the presence and the absence of 6 M guanidine hydrochloride. The use of NEM under denaturing conditions led to incorporation of more than 2 mol of reagent/mol of ectodomain dimer (2.4 and 3.1 in separate experiments). In the absence of denaturant, the extent of labeling was much lower (ϳ0.01 mol/mol ectodomain). SDS-PAGE followed by autoradiography (data not shown) showed that NEM labeled predominantly the ␤Ј-chain. Reduction and carboxymethylation of the [ 3 H]NEM-labeled IR ectodomain, followed by gel filtration chromatography, allowed the separation of the two chains and confirmed that the label was predominantly on the ␤Ј-chain (Fig. 5a) . Peaks A and B were Peptides were chromatographed on a Vydac C8 column (150 ϫ 2.1 mm) at 0.2 ml/min. A, separation of peptides generated by tryptic digestion of fraction 5 using a gradient of 5-100% buffer B in 60 min. Inset, rechromatography of fraction 5T-26. Column, Vydac C18 (50 ϫ 2.1 mm), gradient 27-60% buffer B in 34 min. B, separation of peptides generated by endoproteinase Lys-C digestion of fraction 5 using a gradient of 5-60% buffer B in 58 min.
both derived from the ␣-chain, whereas peak C was the labeled ␤Ј-chain as shown by comparison of the reduced and nonreduced SDS-PAGE (Fig. 5b) .
Digestion of NEM-labeled ␤Ј-chain (peak C, Fig. 5a ) with endoproteinase Lys-C in the presence of 0.02% (w/v) Tween 20 produced several labeled peaks on RP-HPLC (Fig. 6A ) that were combined and subjected to rechromatography (Fig. 6B) . Peak 2 (Fig. 6B) TBSA was added, and the mixture was chromatographed in two runs on a Superdex 200 HR 10/30 column (AMRAD Pharmacia) equilibrated with TBSA at a flow rate of 0.5 ml/min. Aliquots (5 l) of each 0.5-ml fraction were counted in a scintillation counter. Peaks were pooled as indicated and concentrated by ultrafiltration (Centricon 10; Amicon). Aliquots of the concentrated fractions were subjected to PAGE under either reducing or nonreducing conditions as indicated; the resulting gels were then stained for protein and subjected to autoradiography as described under "Experimental Procedures." a, elution profile. b, PAGE of fractions A, B, and C.
884 the PTH derivative of NEM-labeled cysteine was found, indicating that the residue at position 884 was cysteine. The same sequence was found in peaks 1 and 3 (Fig. 6B) , although for each of these fractions an additional sequence was seen indicating that the fraction contained more than one peptide.
DISCUSSION
The IR and epidermal growth factor receptor have been shown to be structurally related and to contain homologous domains including repeat sequences in the cysteine-rich regions (6) . This analysis has been extended (7) to show that the cysteine-rich regions of these two receptors have repeats of the structural motif found in the tumor necrosis factor receptor. A related repeat motif involving 8 cysteine residues was detected in laminin (7) . These observations allowed the prediction (7) of the disulfide bonding patterns in IR, epidermal growth factor receptor, and laminin, the last being confirmed by the recently published three-dimensional structure of the first three domains of laminin (27) .
The results of the present study are summarized and illustrated in Fig. 7 , which shows schematically the IR disulfide bonds currently known, including those previously identified (16) . In this study we have established the intrachain disulfide bond between Cys 8 and Cys 26 in the L1 domain as well as clarifying the arrangement of disulfide bonds in the C-terminal half of the IR ectodomain. An intrachain disulfide linkage between the ␤-chain residues Cys 798 and Cys 807 in the predicted F and G strands of the first Fn III domain (9) was confirmed. Interestingly, the reported sequence for rat IR (28) shows a serine residue at the position equivalent to Cys 807 in human IR, suggesting that the rat IR does not have the intrachain disulfide bond. Also established was an ␣-␤ interchain disulfide bond between Cys 647 in the predicted E strand of the first Fn III repeat and Cys 872 in the CЈ strand of the second Fn III repeat (9) . This latter link is consistent with the mutagenesis data of Cheatham and Kahn (19) and the predictions of Ward et al. (7) but differs from the predictions made by Schaefer et al. (9) , who suggested disulfide links between the ␤ chain cysteines 798, 807, 872, and 884. Their suggestion was based on alignment of the Fn III domains of the IR with those of the growth hormone receptor (9, 29) . The structural implications of the disulfide bond between Cys 647 and Cys 872 are that the two Fn III repeats are aligned side by side and not end to end as is the common configuration (29 -31) .
Evidence was also found for ␣-␣ disulfide bonds, in addition to Cys 524 , with the isolation of the peptide His 670 -Lys 687 from the insert domain in the ␣-chain (Fig. 7) . This peptide includes the triplet of cysteine residues at 682, 683, and 685 and was shown to be a dimer by mass spectrometry. Our data clearly show that at least one of the cysteines at positions 682, 683, and 685 participates in an ␣-␣ interchain dimer bond, although it is not possible from these data to determine which one of the three is involved. The other two cysteines may form a small disulfide-bonded loop (7) or may form additional ␣-␣ dimer bonds. The sequence around this triplet resembles those found in the hinge region of antibodies (32) . Arguments to support the suggestion that there are additional dimer bonds upstream of Cys 524 have been presented (7) based largely on the observation that the 110-kDa fragment obtained following tryptic digestion of the IR runs on nonreduced gels as a monomer (33) . From the results of N-terminal sequence analysis (34) this fragment was thought to comprise the ␤-chain plus the entire C terminus of the ␣-chain starting at Ser 583 . For this fragment to be monomeric it must have lost the ␣-␣ dimer bond in the cysteine triplet either by disulfide reduction during digestion or by an additional tryptic cleavage between the ␣-␤ disulfide bond at Cys 647 and the cysteine triplet. Evidence was presented to show that Cys 884 is present as a free thiol in the recombinant IR ectodomain. It was recovered cross-linked to Trp 632 after enzymatic digestion of a fraction from the initial CNBr digest. This cross-link was not reduced by TCEP and was thus not present in the native receptor, which is readily reduced by trialkyl phosphines to give free ␣-and ␤-chains (14) . The possibility that this cross-link was formed during the initial CNBr reaction has been confirmed by the demonstration that the amino acid tryptathionine is formed during the reaction between cysteine, tryptophan, and CNBr and that the reaction has an absolute requirement for a free thiol group (20) .
Alkylation of recombinant IR ectodomain with labeled NEM in the presence of 6 M guanidine hydrochloride confirmed the presence of one thiol group per ␣␤Ј monomer. Digestion of the ␤Ј subunit derived from NEM-labeled ectodomain lead to the isolation of a labeled peptide that confirmed that the thiol was Cys 884 . A number of studies have indicated that the ␣␤ monomer of the IR has a single thiol group that is located on the ␤-chain and is readily alkylated by NEM in the absence of disaggregating agents (13, 14) . Alkylation of the thiol of the native receptor with NEM has been shown to inhibit the tyrosine kinase activity of the receptor (35) ; inhibition by NEM is more effective in the presence than in the absence of insulin (36) and the IR is protected from alkylation with NEM by ATP or a nonhydrolyzable analogue (14) . These observations suggest that the thiol alkylated is located near the enzyme active site and is thus one of the 6 intracellular Cys residues. However, the kinase activity of receptors in which each of the 6 intracellular cysteine residues had been separately mutated to alanine was the same as that of the wild type receptor and was similarly inhibited by NEM (37) , implying that the reactive thiol is not one of the 6 intracellular Cys residues but is located in the extracellular domain. (16) . Residues are numbered according to Ebina et al. (1) . Vertical arrows indicate the positions of methionine residues, and the CNBr peptides resulting from cleavage at these residues are shown as CN1-CN13. Also shown are the two homologous domains, L1 and L2, separated by the cysteine-rich domain (CysRich), the connecting domain (CD), and two fibronectin III repeats (Fn1 and Fn2) with the first of these including an insert domain (ID).
